title: Primary lymphoma of the esophagus in a patient with AIDS.
authors.affiliation: Department of Clinical Microbiology, Hadassah Medical Center, Hebrew University Medical School, Jerusalem, Israel.
authors.forename: A E
authors.initials: AE
authors.lastname: Moses
authors.forename: G
authors.initials: G
authors.lastname: Rahav
authors.forename: A I
authors.initials: AI
authors.lastname: Bloom
authors.forename: E
authors.initials: E
authors.lastname: Okon
authors.forename: A
authors.initials: A
authors.lastname: Polliack
authors.forename: S
authors.initials: S
authors.lastname: Maayan
authors.forename: J
authors.initials: J
authors.lastname: Zimmerman
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004935:Esophageal Diseases / Q000175:diagnosis / Q000188:drug therapy; D004938:Esophageal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D004945:Esophagoscopy; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000175:diagnosis* / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D014456:Ulcer / Q000175:diagnosis / Q000188:drug therapy; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone